PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 290 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Central Ohio teachers get hands-on biotech training

10tv.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial

STATOriginal source
🌍discoverynews.google.comTier 2 · Trade media

RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

ITM cancer drug spurned by FDA over manufacturing qualms

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Blinkit Faces Food Licence Suspension After FDA Finds 'Cockroach Infestation' In Mumbai Unit

NDTV ProfitOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Innovative macrophage therapies to transform treatment paradigm of solid tumors

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Reconfigurable Colloids For Therapeutic Applications

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Exploring Genetic Resource of Wild Rice Species for Neo-domestication

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: MOdular Reconfigurable Platform for Health and Environmental Universal Sensing

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics (TENX) Shares Collapse 89% After Phase 3 Tria

GuruFocusOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Early clinical development of first-in-class EGL-001 targeting Tregs in head and neck squamous cell carcinoma, supported by AI-based pathomics

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Establishing Cancer Mission Hubs: beyond Networks and Synergies

CORDISOriginal source
🌍discoverynews.google.comTier 2 · Trade media

In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health Plans, PBMs Wary of TrumpRx Impact on Patients

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Bristol Myers Squibb facility coming to Generation Park

FOX 26 HoustonOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bristol Myers Squibb opening pharmaceutical manufacturing campus near Houston

FOX 26 HoustonOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHS moves to tighten oversight of food ingredients as safety concerns mount

cnbc.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA seeks to close decadeslong loophole for food additives

CNNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TNX-103 Misses Primary Endpoint in Phase 3 LEVEL PH-HFpEF Trial

HCPLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Secretary Kennedy Announces Landmark Food Policy Reforms to Advance President Trump’s MAHA Agenda

HHS.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 2 data: ABCL635 reduces frequency, severity of VMS symptoms

Contemporary OB/GYNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA panel to weigh Grail’s Galleri test

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical quality controls fuel expansion of Karl Fischer titration reagent market through 2035

IndiatimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. slated to unveil plan targeting loophole that allows chemicals in food supply

washingtonpost.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech in spotlight: Earnings test Carvykti momentum

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Did TENX Stock Crash 89% Today?

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CTT Pharmaceutical Holdings CEO acquires $500 in CTTH stock

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune Food Safety Crackdown: FDA Suspends 12 Licences, Seizes 198 Kg Mitha Mawa

Punekar NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From five-star kitchens to dark stores: Food safety raids expose India's hidden crisis

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust PLC - Net Asset Value(s)

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial

Dermatology TimesOriginal source
🌍Associationasn-online.orgTier 2 · Direct publisher

Loan Mitigation Program: Deadline Extended

American Society of NephrologyOriginal source
🌍Industryeikontx.comTier 1 · Company source

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Eikon TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo

pharmexec.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Teva Pharmaceutical Stock Surged This Week

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech Q2 loss widens to $3.8M, EPS misses estimates

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results

ibtimes.com.auOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Real-world study provides new insights into safety of new Alzheimer's drug lecanemab

medicalxpress.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics (TENX) Shares Collapse 84% on Failed Phase 3 Trial Results

BlockonomiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Estima CEO: Generative AI reshapes pharmaceutical value proof

itbrief.co.ukOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Labcorp nabs FDA green light for BRAF melanoma diagnostic

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Global drugmakers invest billions to boost U.S. presence

BNN BloombergOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Digital Agriculture Drives a New Generation of Biological Solutions for Nematode Control

AgrolatamOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

We asked 19 biotech leaders what breaks their deals. It wasn’t the science.

Labiotech.euOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Prepyloric Gastric Ulceration Associated With Intermittent Nonsteroidal Anti-inflammatory Drug (NSAID) Use and Unintentional Exposure Through Herbal Supplements: A Case Report

CureusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Danish Biotechs Attracting Investor Attention

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway

The Manila TimesOriginal source
🇺🇰Researchmft.nhs.ukTier 2 · Direct publisher

Manchester researchers lead the way in large-scale medication adherence screening

Manchester University NHS Foundation TrustOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech veteran with 25 years’ experience joins Ernexa board

Stock TitanOriginal source
🇺🇸Industrybristolmyers2016ir.q4web.comTier 3 · Secondary coverage

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol-Myers Squibb NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IAS Tukaram Mundhe's Strict Order: Maharashtra FDA Labs to Operate 7 Days a Week; 'Shirkers' Can Resign

indianmasterminds.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Investing News NetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA CVM targets animal drug gaps with new blueprint, manufacturing pilot program

American Veterinary Medical AssociationOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Drug Raid Takes Unexpected Turn as Pune Cops Find 1,200 Kg of Suspected Khoya

Pune MirrorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

The Manila TimesOriginal source